Elixinol gains on announcing leadership changes, operational review

Elixinol Wellness

28/03/2022 04:11

** Shares of Elixinol Global  EXL.AX  rise as much as 7.3%
to A$0.059, hit their highest since Feb. 17
    ** Medicinal cannabis maker says appointed Ron Dufficy as
interim global CEO, effective April 8; says identified measures
to reduce operating costs by about A$3.2 mln ($2.40 mln) on
annualized bases  urn:newsml:reuters.com:*:nASX22JbxV
    ** Announces resignation of Oliver Horn as global CEO, says
Horn to remain on the board as non-executive director
    ** Adds that the board is focused on moving co to be asset
light, e-commerce led business
    ** Stock on track to record its third straight session of
gains
    ** Stock has fallen 23.6% this year, as of last close

($1 = 1.3307 Australian dollars)

 (Reporting by Jaskiran Singh in Bengaluru)
 ((Jaskiran.Singh@thomsonreuters.com;))